Escalon Medical Corp. reported unaudited consolidated earnings results for the first quarter ended September 30, 2015. For the quarter, the company reported net revenues of $2,781,322 against $2,630,320 a year ago.

Loss from operations was $293,209,000 against $440,235,000 a year ago. Loss from continuing operations was $293,189,000 against $440,196,000 a year ago. Net loss was $293,189,000 against $458,959,000 a year ago.

Basic and diluted net loss per share from continuing operations was $0.04 against $0.06 per share a year ago. Net loss was $0.04 against $0.06 per share a year ago. Research and development expenses for the first quarter increased by 11.1% to $360,000 from $324,000 in the year ago period and were associated with the focused introduction of new and enhanced products.